Todisco Joseph
SEC CIK 1774807 · EDGAR
BoughtSold
Most active insiders at TLPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Angotti Vincent J. | CEO, Dir | $211.2K | — |
| 2 | ASADORIAN RAFFI | CFO | $36.5K | — |
| 3 | Aslam Shakil | Chief Medical Off | $28.4K | — |
| 4 | Dasu Badri N | Chief Engineering Off | $28.4K | — |
| 5 | JAIN ABHINAV | Dir | — | — |
| 6 | Bozilenko Marina | Dir | — | — |
| 7 | Todisco Joseph | Dir | — | — |
| 8 | Broadfoot Jill Marie | Dir | — | — |
| 9 | ADAMS ADRIAN | Dir | — | — |
| 10 | WAN MARK A | Dir | — | — |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 17:14 | 2026-06-22 | TLPH | TALPHERA, INC. | Todisco Joseph | Dir | A - Grant | $0.00 | +5,100 | 11.5K | +80% | $0 |
| 2026-02-06 | 2026-02-04 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +77.2K | 774.7K | +11% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +225.9K | 724.9K | +45% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $7.27 | -27.3K | 697.6K | -4% | -$198.5K | |
| DM | 2026-01-20 | 2026-01-12+ | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $6.94 | -40.1K | 499.0K | -7% | -$278.2K |
| D | 2026-01-20 | 2026-01-16 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +29.6K | 521.7K | +6% | +$100.0K |
| D | 2025-12-19 | 2025-12-18 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | M - OptEx | $4.43 | +30.0K | 539.5K | +6% | +$132.9K |
| D | 2025-12-19 | 2025-12-18 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | S - Sale+OE | $12.00 | -30.0K | 509.5K | -6% | -$360.0K |
| D | 2025-10-16 | 2025-10-15 | TLPH | TALPHERA, INC. | Todisco Joseph | Dir | A - Grant | $0.00 | +6,397 | 6,397 | New | $0 |
| 2025-09-12 | 2025-05-10 | CRMD | CorMedix Inc. | Todisco Joseph | CEO | F - Tax | $11.66 | -21.2K | 509.5K | -4% | -$247.5K | |
| D | 2025-09-12 | 2025-09-12 | CRMD | CorMedix Inc. | Todisco Joseph | CEO | S - Sale+OE | $13.00 | -50.0K | 509.5K | -9% | -$650.0K |
| D | 2025-09-12 | 2025-09-12 | CRMD | CorMedix Inc. | Todisco Joseph | CEO | M - OptEx | $3.47 | +50.0K | 559.5K | +10% | +$173.5K |
| D | 2025-04-02 | 2025-04-01 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +59.2K | 530.7K | +13% | +$200.0K |
| 2025-01-22 | 2025-01-17 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +187.5K | 495.5K | +61% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $12.17 | -24.0K | 471.6K | -5% | -$291.8K | |
| 2025-01-14 | 2025-01-10 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $11.19 | -17.8K | 308.0K | -5% | -$199.5K | |
| 2024-05-13 | 2024-05-10 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $5.17 | -27.0K | 325.9K | -8% | -$139.5K | |
| 2024-03-14 | 2024-03-13 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $3.74 | +13.6K | 352.8K | +4% | +$50.7K | |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +133.3K | 353.1K | +61% | $0 |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $3.47 | -13.8K | 339.3K | -4% | -$47.8K |
| 2023-09-08 | 2023-09-08 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $3.71 | +10.0K | 219.7K | +5% | +$37.1K | |
| A | 2023-05-18 | 2023-05-17 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $4.58 | +5,000 | 209.7K | +2% | +$22.9K |
| 2023-05-17 | 2023-05-17 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $4.58 | +5,000 | 209.7K | +2% | +$22.9K | |
| T | 2023-05-12 | 2023-05-10 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | F - Tax | $5.30 | -37.4K | 204.7K | -15% | -$198.4K |
| 2022-11-16 | 2022-11-15 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $3.82 | +20.0K | 242.2K | +9% | +$76.4K | |
| 2022-08-25 | 2022-08-24 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $3.92 | +4,700 | 222.2K | +2% | +$18.4K | |
| 2022-05-17 | 2022-05-16 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | P - Purchase | $3.38 | +10.0K | 217.5K | +5% | +$33.8K | |
| D | 2022-05-12 | 2022-05-10 | CRMD | CorMedix Inc. | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +207.5K | 207.5K | New | $0 |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | M - OptEx | — | +4,442 | 328.8K | +1% | — |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | F - Tax | $3.40 | -1,562 | 327.2K | -0.5% | -$5,311 |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | M - OptEx | — | +37.7K | 311.0K | +14% | — |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | F - Tax | $4.45 | -13.2K | 324.3K | -4% | -$58.9K |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | F - Tax | $4.59 | -11.1K | 299.9K | -4% | -$51.0K |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | M - OptEx | — | +29.7K | 311.0K | +11% | — |
| 2021-12-03 | 2021-12-02 | AMRX | Amneal Pharmaceuticals, Inc. | Todisco Joseph | EVP | S - Sale | $4.10 | -1,500 | 281.3K | -0.5% | -$6,150 |
Purchase Sale Sale after option exercise All abbreviations